Novo Nordisk (NVO 0.55%) has dropped over 50%, but its expanding GLP-1 pipeline and bold $5.2 billion acquisition could drive the next phase of explosive growth. With analysts turning bullish, investors might be looking at one of 2025's biggest comeback stories.
Stock prices used were the market prices of Oct. 28, 2025. The video was published on Nov. 3, 2025.
